Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities
Go back to Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities| (NASDAQ: CLBT) | Delayed: 16.13 +0.19 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.94 | 52 Week High | $ | |||
| Open | $16.31 | 52 Week Low | $ | |||
| Day High | $16.54 | P/E | N/A | |||
| Day Low | $15.92 | EPS | $ | |||
| Volume | 2,086,564 | |||||
| (NASDAQ: CLBTW) | Delayed: 5.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.25 | 52 Week High | $ | |||
| Open | $5.25 | 52 Week Low | $ | |||
| Day High | $5.25 | P/E | N/A | |||
| Day Low | $5.25 | EPS | $ | |||
| Volume | 3,100 | |||||
